Suzanne Conzen to Cystadenocarcinoma, Serous
This is a "connection" page, showing publications Suzanne Conzen has written about Cystadenocarcinoma, Serous.
Connection Strength
1.327
-
Investigation of selective glucocorticoid receptor modulation in high-grade serous ovarian cancer PDX models. J Gynecol Oncol. 2025 Jan; 36(1):e4.
Score: 0.817
-
Glucocorticoid receptor activation inhibits chemotherapy-induced cell death in high-grade serous ovarian carcinoma. Gynecol Oncol. 2015 Sep; 138(3):656-62.
Score: 0.439
-
Administration of glucocorticoids to ovarian cancer patients is associated with expression of the anti-apoptotic genes SGK1 and MKP1/DUSP1 in ovarian tissues. Clin Cancer Res. 2009 May 01; 15(9):3196-204.
Score: 0.071